Latest Daiichi Sankyo Stories
RnRMarketResearch.com adds “Dermatitis – Pipeline Review, H1 2015” to its store.
RnRMarketResearch.com adds "Liposarcoma Global Clinical Trials Review, H1, 2015 and Liposarcoma - Pipeline Review, H1 2015" to its store.
PARSIPPANY, N.J., April 1, 2015 /PRNewswire/ -- Daiichi Sankyo, Inc., the US subsidiary of Daiichi Sankyo Company, Ltd, announced today that it will merge with its US-based sister company, Asubio
DALLAS, March 26, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Thalassemia - Pipeline Review, H1 2015" therapeutic market research report of 100 pages with latest updates,
Beginning today, integration to focus on enhancing productivity MUMBAI, India, March 25, 2015 /PRNewswire/ -- Sun Pharmaceutical Industries Ltd.
SAN FRANCISCO, March 19, 2015 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) reported that partner AstraZeneca today announced a co-commercialisation agreement with Daiichi Sankyo, Inc.
PARSIPPANY, N.J., March 19, 2015 /PRNewswire/ -- Daiichi Sankyo, Inc.
NEW YORK, March 12, 2015 /PRNewswire/ -- AbbVie's recent acquisition of Pharmacyclics for $21 billion strengthens AbbVie's already comprehensive pipeline and increases the company's growth prospects,
JUPITER, Fla., and PARSIPPANY, N.J., March 12, 2015 /PRNewswire/ -- Charleston Laboratories, Inc.
- An armed gangster.